Oral Curcumin for Thumb Carpometacarpal Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial

Purpose Thumb carpometacarpal osteoarthritis (CMC1-OA) is a prevalent degenerative condition with limited effective nonsurgical treatments. Curcumin has shown anti-inflammatory effects and clinical benefit in lower-extremity osteoarthritis but has not been evaluated in hand osteoarthritis. This study evaluated the efficacy of oral curcumin supplementation in symptomatic CMC1-OA. Methods A prospective, double-blind, randomized, placebo-controlled crossover trial enrolled adults aged ≥40 years with radiographically confirmed CMC1-OA. All participants received a thumb carpometacarpal orthosis and home exercise program. Participants were randomized 1:1 to curcumin (500 mg twice daily) or placebo for 8 weeks, followed by a 2-week washout and crossover for an additional 8 weeks. The primary outcome was change in visual analog scale pain. Secondary outcomes included grip and pinch strength, Kapandji score, Patient-Reported Outcomes Measurement Information System Global Health 10-item questionnaire, Single Assessment Numeric Evaluation, Australian/Canadian Osteoarthritis Hand Index, and Disabilities of the Arm, Shoulder, and Hand. Assessments were performed at baseline and after each treatment phase. Results Twenty participants (14 women; mean age 64.3 years) completed the study with 100% adherence. No statistically significant difference in visual analog scale pain was observed between curcumin and placebo. Secondary outcomes, including Patient-Reported Outcomes Measurement Information System Global Health 10-item questionnaire, Australian/Canadian Osteoarthritis Hand Index, Disabilities of the Arm, Shoulder, and Hand, grip strength, pinch strength, and Kapandji score, similarly showed no significant differences. A decrease in right-hand Single Assessment Numeric Evaluation scores occurred with curcumin, whereas placebo was associated with small bilateral Single Assessment Numeric Evaluation improvements, suggesting a nontreatment-specific effect. No adverse events or clinically significant laboratory changes occurred. Conclusions Oral curcumin (1,000 mg daily for 8 weeks) did not improve pain, function, or strength in CMC1-OA. Although well tolerated, these findings do not support curcumin as an effective standalone nonsurgical treatment at this dose and duration. Clinical relevance Curcumin, at the dose and duration studied, does not provide meaningful clinical benefit for thumb carpometacarpal osteoarthritis and should not be recommended as a standalone nonsurgical treatment.

Authors

Institutions

Publication Details

Journal
Journal of Hand Surgery Global Online
Published
2026-11-18
DOI
https://doi.org/10.1016/j.jhsg.2026.101191
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Oral Curcumin for Thumb Carpometacarpal Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial

Ava G. Chappell, Kasparas Zilinskas, Brent R. DeGeorge, Abhinav Bobby Chhabra et al.
2 links
Journal of Hand Surgery Global Online
Osteoarthritis Treatment and Mechanisms
article

Oral Curcumin for Thumb Carpometacarpal Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial

Ava G. Chappell, Kasparas Zilinskas, Brent R. DeGeorge, Abhinav Bobby Chhabra, Virginia Bailey, Tam Le
article en

Abstract

Purpose Thumb carpometacarpal osteoarthritis (CMC1-OA) is a prevalent degenerative condition with limited effective nonsurgical treatments. Curcumin has shown anti-inflammatory effects and clinical benefit in lower-extremity osteoarthritis but has not been evaluated in hand osteoarthritis. This study evaluated the efficacy of oral curcumin supplementation in symptomatic CMC1-OA. Methods A prospective, double-blind, randomized, placebo-controlled crossover trial enrolled adults aged ≥40 years with radiographically confirmed CMC1-OA. All participants received a thumb carpometacarpal orthosis and home exercise program. Participants were randomized 1:1 to curcumin (500 mg twice daily) or placebo for 8 weeks, followed by a 2-week washout and crossover for an additional 8 weeks. The primary outcome was change in visual analog scale pain. Secondary outcomes included grip and pinch strength, Kapandji score, Patient-Reported Outcomes Measurement Information System Global Health 10-item questionnaire, Single Assessment Numeric Evaluation, Australian/Canadian Osteoarthritis Hand Index, and Disabilities of the Arm, Shoulder, and Hand. Assessments were performed at baseline and after each treatment phase. Results Twenty participants (14 women; mean age 64.3 years) completed the study with 100% adherence. No statistically significant difference in visual analog scale pain was observed between curcumin and placebo. Secondary outcomes, including Patient-Reported Outcomes Measurement Information System Global Health 10-item questionnaire, Australian/Canadian Osteoarthritis Hand Index, Disabilities of the Arm, Shoulder, and Hand, grip strength, pinch strength, and Kapandji score, similarly showed no significant differences. A decrease in right-hand Single Assessment Numeric Evaluation scores occurred with curcumin, whereas placebo was associated with small bilateral Single Assessment Numeric Evaluation improvements, suggesting a nontreatment-specific effect. No adverse events or clinically significant laboratory changes occurred. Conclusions Oral curcumin (1,000 mg daily for 8 weeks) did not improve pain, function, or strength in CMC1-OA. Although well tolerated, these findings do not support curcumin as an effective standalone nonsurgical treatment at this dose and duration. Clinical relevance Curcumin, at the dose and duration studied, does not provide meaningful clinical benefit for thumb carpometacarpal osteoarthritis and should not be recommended as a standalone nonsurgical treatment.

Journal of Hand Surgery Global OnlineVol. 9(1)
University of Virginia (US)
American Foundation for Surgery of the Hand
Good health and well-being
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon